Putting the laboratory in people's hands.
Qanik DX was founded on a simple idea: people should be able to measure what is happening in their own bodies, accurately and when it matters, without waiting days for a laboratory. Decentralised testing lowers healthcare costs and leads to better outcomes.
From a precision-health project to a quantum biosensor.
- 2015
Sonya Satveit leads Open Source Health, the first precision-health project for women with PCOS, and sees how little hormone data exists.
- 2019
The qLMI measurement method is filed, with priority from 11 February 2019, by our photonics and chemistry team in Tallinn, Estonia.
- 2020–2021
Qanik-funded work designs and confirms peptide receptors against the SARS-CoV-2 spike protein, published in peer-reviewed and preprint papers.
- 2023
First US patent granted: US 11,650,205.
- 2024–2026
Two continuations granted. Estradiol validated in serum. Receptors validated on live respiratory viruses. MiniLab cartridge specified for tooling.
Three disciplines, one detection method.
Photonics
Spectral fluorescence signatures read many substances at once by their colour patterns, a technique our team has published on since the 1990s.
Computational biochemistry
Neural networks running on supercomputers design receptors that bind a chosen target, compressing years of discovery into months.
Organic synthesis
We make the receptors, quantum-dot conjugates and functionalised biochips ourselves, on a production process designed to scale.
The team
Founders and leadership
Sonya Satveit
CEO and Founder
Entrepreneur and health advocate. Founder of Open Source Health. Published on AI and gender bias in healthcare; two patents in quantum biophysics.
Gary Bartholomew
Chairman, CTO and Co-Founder
Builds technology companies and large-scale cloud systems. Thirty years in capital markets and more than fifteen companies taken to acquisition or public offering.
Dr. Sergey Babichenko
Chief R&D Officer and Co-Founder
Laser and spectroscopy technologies. Two medical devices commercialised, 120 scientific papers and 12 patents. Lead inventor of qLMI.
Scientists
Dr. Larisa Poryvkina
Chief Scientist, Photonics
Applied spectroscopy, laser remote sensing and fluorescence. Senior Scientist of the Estonian Academy of Sciences; 86 publications and 8 patents.
Dr. Aleksei Kuznetsov
Chief Chemist
Computational biochemistry. Research Associate, Chair of Organic Chemistry, University of Tartu; 28 papers and 2 patents.
Dr. Anton Mastitski
Research Associate, Organic Chemistry
Synthetic biology and organic chemistry using computational AI. Co-inventor on the qLMI patents.
Advisers
Dr. Jean-Luc Gala, MD, PhD
Microbiology and Biological Threats
Professor, Center for Applied Molecular Technologies. Head of an EU military CBRN biological threat unit and United Nations investigator of biological threats.
Fred Trotter
Data Science and Privacy
Founder of CareSet Systems, which built one of the largest Medicare datasets in the US. Author of Hacking Healthcare.
Doug Ross
Clinical and Regulatory Compliance
25 years bringing US healthcare products from pipeline to commercialisation.
Dr. Edison de Mello, MD, PhD
Medical Adviser
Integrative health physician, UCLA Medical Center. Psychotherapist and author.
Dr. Fiona McCullough, ND
Medical Adviser
Naturopathic physician and author; PCOS and women's health specialist.
Partners, licensees and investors.
We are talking with a small number of companies about taking MiniLab and BioSafety to market.
- →Technology and applications: see the platform